Cargando…
Photochemical activation of MH3-B1/rGel: a HER2-targeted treatment approach for ovarian cancer
HER2-targeted therapy has been shown to have limited efficacy in ovarian cancer despite frequent overexpression of this receptor. Photochemical internalization (PCI) is a modality for cytosolic drug delivery, currently undergoing clinical evaluation. In the present project we studied the application...
Autores principales: | Bull-Hansen, Bente, Berstad, Maria B., Berg, Kristian, Cao, Yu, Skarpen, Ellen, Fremstedal, Ane Sofie, Rosenblum, Michael G., Peng, Qian, Weyergang, Anette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494949/ https://www.ncbi.nlm.nih.gov/pubmed/26002552 |
Ejemplares similares
-
Photochemically-Induced Release of Lysosomal Sequestered Sunitinib: Obstacles for Therapeutic Efficacy
por: Wong, Judith Jing Wen, et al.
Publicado: (2020) -
Multi-Modality Therapeutics with Potent Anti-Tumor Effects: Photochemical Internalization Enhances Delivery of the Fusion Toxin scFvMEL/rGel
por: Selbo, Pål K., et al.
Publicado: (2009) -
Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin
por: Parameswaran, Reshmi, et al.
Publicado: (2012) -
RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
por: Engebraaten, Olav, et al.
Publicado: (2021) -
Design, Characterization, and Evaluation of scFvCD133/rGelonin: A CD133-Targeting Recombinant Immunotoxin for Use in Combination with Photochemical Internalization
por: Olsen, Cathrine Elisabeth, et al.
Publicado: (2019)